CAS 1234564-95-4

PM 102

CAS : 1234564-95-4

Peptide that reverses the anticoagulant effect of heparin. Potently binds heparin (Kd = 36 nM in vitro).

Formule : C₂₃₅H₄₂₅N₁₁₁O₆₄

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 5830

Ref: TM-TP1959

PM 102

CAS : 1234564-95-4

PM 102 is a drug that inhibits the activity of epidermal growth factor receptor (EGFR) and epidermal growth factor (EGF). It is used as a treatment for colorectal cancer in combination with 5-fluorouracil. It also has been shown to inhibit the growth of human colon carcinomas in vitro. PM 102 has subassemblies that are composed of an inhibitor, which blocks the binding site on the EGFR, and a biotinylated peptide, which binds to the EGFR. This drug has been shown to be non-toxic in rats and does not cause any significant side effects. PM 102 is a nonprofit organization that will provide regulatory guidance for devices used in treatment of diseases such as cancer. The company's goal is to increase translation and enhance transistor enhancements for use in medical devices.

Formule : C₂₃₅H₄₂₅N₁₁₁O₆₄

Degré de pureté : Min. 95%

Masse moléculaire : 5,830 g/mol

Ref: 3D-JZB56495